ePrints

Reply to "Liver Failure in Human Immunodeficiency Virus - Hepatitis C Virus Coinfection Treated with Sofosbuvir, Ledipasvir and Antiretroviral Therapy"

Lookup NU author(s): Dr Jess Dyson, Professor Stuart McPhersonORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

We would like to thank Marchan-Lopez et al. for their letter following our recently published article [1]. They report another case of liver injury related to treatment with sofosbuvir and a NS5A inhibitor (ledipasvir) in a patient with hepatitis C and HIV coinfection. In both cases we described hepatic decompensation occurred within 3 weeks of commencing the antiviral therapy. It is interesting to note that their patient did not decompensate until 2 months after commencing therapy with the DAAs and also had symptoms of abdominal pain and vomiting with no alternative explanation.

Publication metadata

Author(s): Dyson JK, McPherson S

Publication type: Article

Publication status: Published

Journal: Journal of Hepatology

Year: 2016

Volume: 64

Issue: 3

Pages: 753-754

Print publication date: 01/03/2016

Online publication date: 10/12/2015

Acceptance date: 01/01/1900

ISSN (print): 0168-8278

ISSN (electronic): 1600-0641

Publisher: Elsevier

URL: http://dx.doi.org/10.1016/j.jhep.2015.11.038

DOI: 10.1016/j.jhep.2015.11.038

Altmetrics

Share